Safety and Efficacy of Continuous Subcutaneous Levodopa/Carbidopa Infusion for Parkinson's disease: Three-Year Data from the Open-Label BeyoND study
NEUROLOGY(2023)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined